Prime Sciences
Has Prime Sciences received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued Prime Sciences a warning letter naming semaglutide, tirzepatide, retatrutide, cagrilintide and mazdutide, dated Mar 31, 2026, with the FDA subject line “Unapproved New Drugs Sold Over the Internet.”
FDA records in this index name Prime Sciences on Mar 31, 2026.
- Websites the letters name
- prime-sciences.com (see how each letter refers to them)
- Type named in FDA records
- Online seller
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide, Tirzepatide, Retatrutide, Cagrilintide
- Latest record
- Mar 31, 2026
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Mar 31, 2026 | Unapproved New Drugs Sold Over the Internet | Semaglutide, Tirzepatide, Retatrutide, Cagrilintide, Mazdutide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Mar 31, 2026: … 40.4% of patients receiving Cagri compared to 16.2% with semaglutide alone.” “Mechanism of action: Cagrilintide … to 28% body weight reduction, compared to around 15% with semaglutide or Tirzapeptide.” “Retatrutide is a drug that works similarly to semaglutide and tirzepatide, but works in three different … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- prime-sciences.com: FDA’s warning letter of Mar 31, 2026 is addressed to Prime Sciences. It refers to the site in these words: “Food and Drug Administration (FDA) reviewed your website at https://prime-sciences.com/ from January to March 2026.” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.